TY - JOUR
T1 - Development of clinical indicators for type 2 diabetes
AU - MacKinnon, Neil J.
AU - Hartnell, Nicole R.
AU - Black, Emily K.
AU - Dunbar, Peggy
AU - Johnson, Jeffrey
AU - Halliday-Mahar, Susan
AU - Pattar, Rumi
AU - Ur, Ehud
PY - 2008
Y1 - 2008
N2 - Background/Objective: Preventable drug-related morbidity in patients with type 2 diabetes is a major concern. Our objective was to develop a set of Canadian clinical indicators of preventable drug-related morbidity (PDRM) and preventable care-related morbidity (PCRM) for type 2 diabetes. Methods: Each study partner (Dalhousie University, Nova Scotia Department of Health, Diabetes Care Program of Nova Scotia, and Sobeys Pharmacy Group) was asked to identify the priorities of medication-related diabetes care from the Canadian Diabetes Association 2003 clinical practice guidelines using the nominal group technique. Based on the priorities identified, a survey was constructed listing the clinical outcome and pattern of care related to a number of possible PDRMs/PCRMs in patients with type 2 diabetes. Using the Delphi technique, an interdisciplinary panel of 10 experts scored each clinical indicator in an attempt to achieve consensus. Results: Education/reinforcement of targets was identified by the nominal group technique as the most important area in which to improve diabetes care. After 3 rounds of the Delphi technique, 21 consensus-based clinical indicators were generated. Nine indicators were on the initial survey in round 1, and 12 indicators were suggested by the expert panel in rounds 1 and 2. Discussion: The resulting 21 clinical indicators provide clinicians and decision-makers with valuable tools to measure the quality of medication use in patients with type 2 diabetes.
AB - Background/Objective: Preventable drug-related morbidity in patients with type 2 diabetes is a major concern. Our objective was to develop a set of Canadian clinical indicators of preventable drug-related morbidity (PDRM) and preventable care-related morbidity (PCRM) for type 2 diabetes. Methods: Each study partner (Dalhousie University, Nova Scotia Department of Health, Diabetes Care Program of Nova Scotia, and Sobeys Pharmacy Group) was asked to identify the priorities of medication-related diabetes care from the Canadian Diabetes Association 2003 clinical practice guidelines using the nominal group technique. Based on the priorities identified, a survey was constructed listing the clinical outcome and pattern of care related to a number of possible PDRMs/PCRMs in patients with type 2 diabetes. Using the Delphi technique, an interdisciplinary panel of 10 experts scored each clinical indicator in an attempt to achieve consensus. Results: Education/reinforcement of targets was identified by the nominal group technique as the most important area in which to improve diabetes care. After 3 rounds of the Delphi technique, 21 consensus-based clinical indicators were generated. Nine indicators were on the initial survey in round 1, and 12 indicators were suggested by the expert panel in rounds 1 and 2. Discussion: The resulting 21 clinical indicators provide clinicians and decision-makers with valuable tools to measure the quality of medication use in patients with type 2 diabetes.
UR - http://www.scopus.com/inward/record.url?scp=41949091223&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=41949091223&partnerID=8YFLogxK
U2 - 10.3821/1913-701X(2008)141[120:DOCIFT]2.0.CO;2
DO - 10.3821/1913-701X(2008)141[120:DOCIFT]2.0.CO;2
M3 - Article
AN - SCOPUS:41949091223
SN - 1715-1635
VL - 141
SP - 120
EP - 128
JO - Canadian Pharmacists Journal
JF - Canadian Pharmacists Journal
IS - 2
ER -